CFTR rs104894301: Understanding This Rare Genetic Variant
The rs104894301 variant is a rare genetic change located within the CFTR gene. It is recognized in clinical literature for its potential association with cystic fibrosis and related clinical presentations.
What each genotype means
Typical CFTR function
This genotype represents the common, non-variant sequence at this position in the CFTR gene. It is not associated with the specific clinical presentations linked to the variant form of this gene.
This is the most common genotype found in the general population across all ancestries.
CFTR variant carrier
You carry one copy of this variant, which is associated with cystic fibrosis clinical presentations. Being a carrier typically does not cause the full condition, but you should discuss the implications of this result with a genetic counselor or clinician.
This genotype is rare in the general population.
Potential CFTR-related clinical presentation
This genotype indicates the presence of two copies of the variant. Research associates this variant with cystic fibrosis or CFTR-related disorders, which can affect the respiratory, gastrointestinal, and other systems. Please consult with a medical specialist to discuss these findings in the context of your health history.
This genotype is extremely rare in the general population.
What is rs104894301?
The rs104894301 variant is a single nucleotide polymorphism (SNP) found within the CFTR gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is categorized as a rare mutation, meaning it is not commonly found in the general population. Because the CFTR gene is large and complex, researchers track specific variants like rs104894301 to understand how they might alter the function of the protein the gene encodes. When a variant occurs in a gene associated with a recessive condition, it is often studied to determine if it contributes to disease symptoms or if it is a benign change that does not impact health. Geneticists use databases like ClinVar and gnomAD to catalog these variants and assess their frequency and potential clinical impact across different ancestral groups.
The Role of the CFTR Gene
The CFTR gene provides instructions for making the cystic fibrosis transmembrane conductance regulator protein. This protein functions as a channel across the membranes of cells that produce mucus, sweat, saliva, tears, and digestive enzymes. It is responsible for transporting negatively charged particles called chloride ions into and out of cells. This movement of chloride ions helps control the movement of water in tissues, which is necessary for the production of thin, freely flowing mucus. When the CFTR protein is dysfunctional or absent, the mucus becomes thick and sticky, which can lead to blockages and infections in the lungs, pancreas, and other organs. Because of its critical role in maintaining fluid balance, mutations in the CFTR gene are the primary cause of cystic fibrosis, a condition that affects the respiratory and digestive systems.
Research and Clinical Associations
Research into rs104894301 focuses on its potential to disrupt normal CFTR protein function. Clinical evidence for rare variants is often gathered through case studies and diagnostic testing of individuals presenting with symptoms of cystic fibrosis or CFTR-related disorders, such as chronic pancreatitis or bronchiectasis. Because this variant is rare, the evidence strength is currently considered moderate. Scientists look for evidence of pathogenicity by analyzing whether the variant is found in individuals with clinical symptoms and by using computational models to predict if the change in the DNA sequence will damage the resulting protein. It is important to note that the presence of a variant does not automatically equate to a diagnosis. Clinical interpretation requires a comprehensive review of an individual's symptoms, family history, and other genetic factors by a qualified healthcare professional.
Population Frequency
The rs104894301 variant is classified as rare in the general population. Population frequency data, such as that found in the Genome Aggregation Database (gnomAD), is essential for determining how often a variant appears in healthy individuals versus those with specific conditions. For rare variants, the frequency is often so low that it is difficult to establish a clear statistical association with disease without large-scale studies. Because frequencies can vary significantly between different ethnic and ancestral groups, a variant that is rare in one population might be slightly more common in another. Researchers continue to collect data to refine these frequency estimates, which helps clinicians distinguish between common benign variations and rare, potentially pathogenic mutations.
Navigating Genetic Information
If you have received information about the rs104894301 variant through genetic testing, it is important to understand what this means for your health. Genetic testing results can be complex and are often best interpreted in the context of a clinical consultation. You cannot diagnose yourself or determine your health risks based solely on a single variant report. If this variant was identified in a clinical report, discuss the findings with a genetic counselor or a physician who specializes in genetics. They can help explain the significance of the variant, whether it requires further testing, and how it relates to your specific health history. Avoid making medical decisions based on online information alone, as clinical context is essential for accurate assessment and care.
How common is this variant?
The rs104894301 variant is considered rare across most global populations, with specific frequency data often limited in large-scale databases.
Frequently asked questions
Is rs104894301 a cause of cystic fibrosis?
The rs104894301 variant is a known mutation associated with cystic fibrosis clinical presentations. However, whether it causes disease depends on the presence of other variants and the specific clinical context of the individual.
What should I do if I have this variant?
If you have identified this variant through testing, you should consult with a genetic counselor or a medical professional. They can provide a clinical interpretation based on your personal and family health history.
Where can I find more information about CFTR variants?
You can search for specific variants on the ClinVar website or review general information about the CFTR gene on MedlinePlus Genetics. These resources provide curated, evidence-based information for the public and clinicians.
Does this variant affect medication response?
Some CFTR variants are associated with responsiveness to specific modulator therapies. You should discuss any potential implications for treatment with your clinician or pharmacist, as they can provide guidance based on your specific genetic profile.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs104894301?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFTR
Severe pathogenic mutation (p.Gly542Ter) associated with cystic fibrosis.
Classic cystic fibrosis in-frame 3-bp deletion variant (p.Phe508del / deltaF508) causing misfolding and impaired chloride channel trafficking.
Pathogenic frameshift mutation (c.3659delC) in CFTR linked to cystic fibrosis.
Pathogenic nonsense variant (p.Gly542Ter / G542X) causing autosomal recessive cystic fibrosis when inherited in trans with another CFTR pathogenic allele.
Also known as p.Arg117His (R117H), this CFTR variant is associated with mild or atypical cystic fibrosis and congenital bilateral absence of the vas deferens, with clinical severity influenced by the poly-T tract background.
A CFTR mutation associated with cystic fibrosis and CFTR-related disorders.
